Product: Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
Reason for recall: Failed Tablet/Capsule Specifications
Recall initiated: 20160518
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated